Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Post by eSnowdenon Jan 23, 2018 3:49pm

205 Views

Post# 27418858

Company needs new blood...

Ok, last press release was over a month ago; shares have basically flatlined as a result. These acquisitions of formulations that will basically add bread crumbs to the bottom line; I don't know what friessen's strategy is going forward--but I am basically falling asleep watching this company's progress. Please, sell the company to Knight Therapeutics or some other game changer that can get this company to the next level.

Bullboard Posts

Near-term and long-term outlook for gold